Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
22 May, 2026, 05.39 PM IST
Forget blood tests, your cell's sugar coat may be the earliest cancer signal we have ever foundA new study shows that over 90% of cancer cases begin with subtle cellular changes before symptoms appear. Scientists now highlight hidden ...
19 May, 2026, 06.41 PM IST
In 1983, Kary Mullis imagined copying DNA while driving through California at night: the idea transformed modern genetics foreverWhile cruising through the scenic highways of California, a visionary scientist named Kary Mullis stumbled upon an extraordinary concept th...
17 May, 2026, 04.26 PM IST
Torrent Group ventures into diagostics business, opens lab in Navi MumbaiTorrent Group has entered the diagnostics market. They have launched Torrent Diagnostics and opened India's largest National Reference Labo...
23 Feb, 2026, 05.51 PM IST
US Stock Market IPO: BillionToOne files initial public offeringBillionToOne develops molecular diagnostic tests — including a non-invasive prenatal screen and liquid biopsy — for diseases.
08 Oct, 2025, 04.07 AM IST
Cepheid opens manufacturing site in Bengaluru to make TB testing cartridgesThe Cepheid manufacturing project was initiated in 2018 to support the Indian market. The local manufacturing of components will make Cephe...
14 Mar, 2023, 07.10 PM IST
Synthetic biology startup D-Nome raises $1.5 million in funding from Ankur Capital, Campus FundD-Nome's focus is to build rapid point-of-care diagnostics for human infectious diseases and other applications using genomics and syntheti...
21 Jan, 2023, 08.56 PM IST
Omicron variant to be detected in 20 minutes by molecular diagnosis testPOSTECH announced on the 10th that a research team led by Professor Lee Jung-wook of the Department of Chemical Engineering has developed m...
13 Dec, 2021, 07.41 AM IST
Swiss pharma giant Roche to buy American firm GenMark Diagnostics for $1.8 billionRoche said it is offering $24.05 a share for GenMark, a premium of some 43 percent to its last quoted share price on February 10.
15 Mar, 2021, 01.48 PM IST
India plans to double testing capacity through new project: C-CAMPThe Rockefeller Foundation has provided financial support for the project executed by the Bangalore Life Science Cluster, which would impro...
03 Sep, 2020, 09.14 PM IST
Mylab launches machine to automate molecular diagnostic tests including those for COVID-19Earlier in March, Mylab had received commercial approval from the Central Drugs Standard Control Organisation (CDSCO) for its COVID-19 test...
07 Jul, 2020, 01.43 PM IST
As demand is high, go for targeted testing: Foundation for Innovative New Diagnostics Chief Access OfficerTesting without symptoms or history of being exposed is wasteful, so there is the controversial idea of “immunity passports” where you test...
19 May, 2020, 11.53 PM IST
At least a week to put testing kits in the market: Molecular diagnostic companiesPrivate molecular diagnostic companies have received licenses to get their tests validated but they cannot sell those kits under the curren...
23 Mar, 2020, 10.38 AM IST
Private labs may soon be allowed to test for coronavirus infectionRoche has also received a licence from the Indian drug regulator for a specific SARS-Covid-19 diagnostic that can test thousands of samples...
18 Mar, 2020, 08.49 AM IST
Motilal Oswal PE fund to invest up to Rs 240 crore in Molbio DiagnosticsMolbio along with its subsidiary Bigtec Labs, has developed and commercialised Truenat, which is claimed to be the world's first commercial...
04 Mar, 2020, 08.54 PM IST
- HLL Lifecare to launch chikungunya, dengue diagonstic kits
HLL Lifecare Limited is all set to foray into molecular diagnostics area with a duplex test kit to make chikungunya and dengue fever tests ...
08 Aug, 2012, 02.53 PM IST
- Dabur OnQuest hopes to get CAP accreditation next year
Dabur OncQuest, a subsidiary of Dabur pharma, is hoping to get accreditation from College of American Pathologists next year.
10 Jun, 2008, 06.53 PM IST